Indefinite Delivery Contract 36E79726D0031
Award Date 8/9/26
Last Date to Order 8/8/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- This single-award Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc. for the supply of Montelukast NA Tablets. The contract has a 1-year base period with four 1-year option periods, for a total potential period of performance through May 9, 2026. The contract ceiling value is $23,863,543.01. The contract aims to provide an uninterrupted source of Montelukast NA Tablets in various package...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Montelukast HCL Chewable Tablets, a leukotriene receptor antagonist commonly used in the treatment of asthma and allergic rhinitis. The contract, valued at $5.72 million with an ultimate completion date of August 8, 2026, was awarded on August 9, 2021, following a pre-solicitation opportunity posted on February 17, 2021. The base year...
- Xlcare Pharmaceuticals Inc. (UEI: MEAUS5WHBJJ7) was awarded a single-award Indefinite Delivery Contract by the National Acquisition Center, a civilian federal agency, on May 10, 2026, to supply Montelukast 10mg tablets to multiple federal healthcare entities. The contract carries a ceiling value of $24.8 million and encompasses a five-year performance period consisting of a base year (May 10, 2026 through May 9, 2027) plus four one-year option periods, with an ultimate completion date of May...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award IDIQ to Avkare LLC for Mycophenolate Mofetil capsules and tablets on June 23, 2025, with a contract ceiling of $24,898,277.30 and no set-aside. The contract covers a one-year base period from June 23, 2025, through June 22, 2026, with four additional one-year option periods extending through June 21, 2027. Place of performance is unrestricted; the contract serves multiple federal agencies including the Veterans...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award indefinite-delivery contract to Avkare LLC on June 16, 2026, with a ceiling of $1,834,297.80 and an ultimate completion date of June 15, 2031. The contract procures Metaxalone 800 MG tablets in 100 and 500 count bottles as a national requirements contract serving the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through DLA and VA prime vendor programs. The...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Avkare, LLC for the procurement of mesalamine tablets. The contract has a one-year base period and four one-year option periods, with a potential value of $22,433,820. The contract aims to provide an uninterrupted supply of mesalamine tablets to the VA, DoD, Bureau of Prisons, and Indian Health Service through the respective pharmaceutical prime vendor programs. The original...
- Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on July 31, 2022, for the supply of Acetazolamide tablets. The contract carries a ceiling value of $2,075,624.60 with an ultimate completion date of July 30, 2026. The ordering period commenced on July 31, 2022, and extends through July 30, 2023, with four one-year options available for...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award, indefinite delivery contract to Avkare, LLC on April 7, 2019 with a potential value of $8,822,654.50. The contract aims to procure zolpidem tablets in various package sizes and strengths for distribution to VA and other government agencies through April 6, 2024. No set-aside provisions were applied. The originating solicitation sought information on industry capabilities to distribute zolpidem tartrate tablets...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Golden State Medical Supply, Inc. on May 9, 2026, for Simvastatin tablets with a ceiling of $16,792,934.72. The contract carries no set-aside designation. Place of performance supports the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through the VA's and DOD's respective Pharmaceutical Prime Vendor Programs nationwide. The originating solicitation,...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award IDIQ to Jubilant Cadista Pharmaceuticals Inc. for Lamotrigine Immediate Release Tablets with a ceiling of $11,913,264.25 on June 16, 2025. The contract has an ordering period from June 16, 2025 through June 15, 2026, with four one-year options extending performance through June 15, 2027. The VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center will utilize the...